APA (7th ed.) Citation

Ru Han, Jorge A. Gomez, Bruna de Veras, Thatiana Pinto, Adriana Guzman-Holst, Javier Nieto, & Désirée A. M. van Oorschot. (2023). How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Ru Han, Jorge A. Gomez, Bruna de Veras, Thatiana Pinto, Adriana Guzman-Holst, Javier Nieto, and Désirée A. M. van Oorschot. How Large Could the Public Health Impact of Introducing Recombinant Zoster Vaccination for People Aged ≥50 Years in Five Latin American Countries Be? Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Ru Han, et al. How Large Could the Public Health Impact of Introducing Recombinant Zoster Vaccination for People Aged ≥50 Years in Five Latin American Countries Be? Taylor & Francis Group, 2023.